Adaptive resistance to RAF inhibitors in melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adaptive resistance to RAF inhibitors in melanoma

Published:2014-06-06 Issue:6 Volume:27 Page:1032-1038
ISSN:1755-1471
Container-title:Pigment Cell & Melanoma Research
language:en
Short-container-title:Pigment Cell Melanoma Res.

Author:

Kugel Curtis H.¹²,Aplin Andrew E.¹³

Affiliation:

1. Department of Cancer Biology and Kimmel Cancer Center; Thomas Jefferson University; Philadelphia PA USA

2. Jefferson College of Graduate Studies; Thomas Jefferson University; Philadelphia PA USA

3. Department of Dermatology and Cutaneous Biology; Thomas Jefferson University; Philadelphia PA USA

Funder

National Institutes of Health

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

Joanna M. Nicolay Melanoma Foundation

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pcmr.12264/fullpdf

Reference46 articles.

1. Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3;Abel;J. Clin. Invest.,2013

2. Adaptive upregulation of FOXD3 and resistance to PLX4032/4720-induced cell death in mutant B-RAF melanoma cells;Basile;Oncogene,2012

3. Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors;Chakrabarty;Proc. Natl Acad. Sci. USA,2012

4. AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity;Chandarlapaty;Cancer Cell,2011

5. EGFR-mediated reactivation of MAPK signaling contributes to insensitivity of BRAF-mutant colorectal cancers to RAF inhibition with vemurafenib;Corcoran;Cancer Discov.,2012

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in Neuroblastoma;Cancers;2024-06-25

2. Protein phosphatase 6 activates NF-κB to confer sensitivity to MAPK pathway inhibitors in KRAS - and BRAF -mutant cancer cells;Science Signaling;2024-05-14

3. Mcl-1 mediates intrinsic resistance to RAF inhibitors in mutant BRAF papillary thyroid carcinoma;Cell Death Discovery;2024-04-15

4. Extracellular Vesicles-Based Cell-Cell Communication in Melanoma: New Perspectives in Diagnostics and Therapy;International Journal of Molecular Sciences;2023-01-04

5. Malignant Melanoma;Holland‐Frei Cancer Medicine;2022-10-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3